Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Initiates Coverage On Rumble with Perform Rating

Oppenheimer analyst Jason Helfstein initiates coverage on Rumble (NASDAQ:RUM) with a Perform rating.
byBenzinga Newsdesk
December 2, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Oppenheimer analyst Jason Helfstein initiates coverage on Rumble (NASDAQ:RUM) with a Perform rating.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Abbvie’s Phase 3 Trial Of Atogepant (Qulipta) For The Preventive Treatment Of Episodic Migraine Met All Primary & Secondary Endpoints And Demonstrated A Statistically Significant Reduction In Monthly Migraine Days Versus Placebo Arm

By Benzinga Newsdesk
April 21, 3:32 AM
AbbVie (NYSE: ABBV) today announced positive data from its Phase 3 ELEVATE study, evaluating atogepant for the preventive treatment of episodic migraine in people who had previously failed two to four classes of oralAbbVie (NYSE:ABBV) today announced positi

ABBV